SEC Comment Letter for REGENERON PHARMACEUTICALS, INC. (REGN) (CIK 0000872589) (REGN) — Jul 23, 2007

REGENERON PHARMACEUTICALS, INC. (REGN) (CIK 0000872589)
Date: July 23, 2007 · CIK: 0000872589 · Accession: 0000000000-07-035627

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-19034

Date

July 18, 2007

Author

Jim B. Rosenberg

Form

UPLOAD

Company

REGENERON PHARMACEUTICALS, INC. (REGN) (CIK 0000872589)

Letter

Mail Stop 6010 Via Facsimile and U.S. Mail July 18, 2007 Dr. Leonard S. Schleifer, M.D., Ph.D President and Chief Executive Officer Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591-6707

Re: Regeneron Pharmaceuticals, Inc. Form 10-K for fiscal year ended December 31, 2006 File No. 000-19034

Dear Dr. Schleifer:

We have completed our review of your Form 10-K and have no further comments at this time.

Sincerely,
Jim B. Rosenberg
Senior Assistant Chief Accountant

Show Raw Text

Mail Stop 6010
Via Facsimile and U.S. Mail

                                                                                                July 18, 2007

Dr. Leonard S. Schleifer, M.D., Ph.D
President and Chief Executive Officer
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591-6707

Re:      Regeneron Pharmaceuticals, Inc.
Form 10-K for fiscal year ended December 31, 2006
            File No. 000-19034

Dear Dr. Schleifer:

We have completed our review of your Form 10-K and have no further comments
at this time.

Sincerely,

Jim B. Rosenberg
Senior Assistant Chief Accountant

SecProbe.io